The data, announced by public health officials across the country, pushed the country’s total COVID-19 cases to 383,132 and its death toll from the virus to 12,211.
To date, a total of 304,888 people — or 79 per cent of all cases — have also recovered from the virus, while over 14,779,000 tests have been administered.
On Tuesday, Canada’s minister of public services and procurement, Anita Anand, said the federal government was in frequent talks with several coronavirus vaccine suppliers to negotiate earlier delivery dates.
Health Canada is currently reviewing the approval of four vaccines, with the government previously estimating an initial rollout of six million doses — enough shots to fully inoculate three million Canadians — to come in the new year.
“The delivery window is within the first quarter of 2021 … I am negotiating with our vaccine suppliers every day for earlier delivery dates. So when the Health Canada approval comes we will kick into the delivery process ASAP,” Anand said.
Coronavirus: Feds provide additional support to Indigenous communities amid outbreaks
Leaked modelling revealed on Tuesday also showed that almost 800 Albertans were projected to be hospitalized with COVID-19 by mid-December, placing an increased strain on hospitals and intensive care units.
Canada currently has over 2,600 hospitalizations from the virus, with the number steadily growing alongside the country’s cases and deaths.
Canada’s chief public health officer, Dr. Theresa Tam, said in a statement Tuesday that the number of people experiencing severe illness continues to increase, with an average of 87 deaths and over 2,250 people being treated in hospital over the past seven days.
Coronavirus: Which COVID-19 treatments are available in Canada?
Ontario tallied the highest number of new COVID-19 cases Tuesday, with 1,707 more infections and seven new deaths. The province, which saw its daily coronavirus cases peak at over 1,800 on Friday, sent several of its hotspots into lockdown last week to curb its surge in new cases.
In Quebec, another 1,177 infections and 28 additional deaths were announced by health authorities Tuesday. The province has the highest number of COVID-19-related deaths in the country, which now stands at 7,084 following Tuesday’s increase.
Alberta reported 1,307 more infections as well, pushing it’s total caseload to 59,484. Ten more deaths were also added by health authorities Tuesday, with its provincial death toll now standing at 551. Manitoba reported another 282 cases while Saskatchewan added 181.
B.C. added 653 more cases on Tuesday, of which three were diagnosed as “epi-linked,” meaning cases that displayed symptoms and were close contacts of confirmed infections, but were never tested. A total of 336 patients are considered epi-linked in the province, while the death toll stands at 457 after 16 more fatalities were announced.
Several territories and Atlantic Canadian provinces reported new cases as well, with Nova Scotia adding 10, New Brunswick another seven and both Newfoundland and Labrador and Nunavut reporting just one.
P.E.I., and the Northwest Territories did not add any new infections, while the Yukon has yet to update its Tuesday case figure.
Coronavirus: Small businesses falling through cracks for government aid
Cases of the virus continue to rise across the world, with 63,679,000 cases being reported as of today according to a tally kept by Johns Hopkins University.
A total of 1,476,900 people have also died from the virus so far, with the United States, Brazil and India leading in both infections and fatalities.
© 2020 Global News, a division of Corus Entertainment Inc.
Reddit community WallStreetBets squeezes short sellers – ABC News
[unable to retrieve full-text content]
- Reddit community WallStreetBets squeezes short sellers ABC News
- 2 short sellers admit defeat, bail out at huge loss as GameStop share surge hits 1000% CBC.ca
- In battle over GameStop shares, two big players flinch CTV News
- Opinion: Why did BlackBerry’s stock triple despite absolutely nothing happening? Over-hyped Reddit posts The Globe and Mail
- Explainer: How retail traders squeezed Wall Street for bets against GameStop Reuters
- View Full coverage on Google News
France's Sanofi to help rival Pfizer-BioNTech make vaccines – Yahoo Canada Finance
REDWOOD CITY, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) — Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, today announced the pricing of an underwritten public offering of 3,750,000 shares of Class A common stock (1,650,000 of which are being offered for sale by Seer and 2,100,000 are being offered for sale by selling stockholders of Seer) at a public offering price of $67.00 per share. In addition, the selling stockholders of Seer have granted the underwriters a 30-day option to purchase up to 562,500 additional shares of Class A common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about February 1, 2021, subject to satisfaction of customary closing conditions. Seer will not receive any proceeds from the sale of shares in the offering by selling stockholders. J.P. Morgan, Morgan Stanley, BofA Securities and Cowen are acting as lead book-running managers for the offering. Registration statements relating to the shares being sold in this offering were declared effective by the Securities and Exchange Commission on January 27, 2021. The offering is being made only by means of a prospectus, copies of which may be obtained, when available, from: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, via telephone: +1 (866) 803-9204, or by emailing email@example.com; Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014; BofA Securities, NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, NC 28255-0001, Attention: Prospectus Department, or by email at firstname.lastname@example.org; and Cowen and Company, LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, via telephone: +1 (833) 297-2926, or by emailing PostSaleManualRequests@broadridge.com. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Seer Seer is a life sciences company focused on enabling exceptional scientific outcomes by commercializing transformative products that will drive breakthrough ideas by unlocking the deep, unbiased biological information that can make them a reality. Seer is developing its Proteograph Product Suite, which is an integrated solution consisting of consumables, automation instrumentation and proprietary software that performs deep, unbiased proteomics analysis at scale in a matter of hours. Seer designed the Proteograph to be efficient and easy-to-use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution broadly available to life sciences researchers. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. Forward-Looking StatementsThis press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements are based on Seer’s beliefs and assumptions and on information currently available to it on the date of this press release. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause Seer’s actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. These statements include but are not limited to statements regarding statements regarding the timing of the proposed public offering and the intended use of proceeds generated from the offering. These and other risks are described more fully in Seer’s filings with the Securities and Exchange Commission (“SEC”) and other documents that Seer subsequently files with the SEC from time to time. Except to the extent required by law, Seer undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made. Investor ContactCarrie Mendivilinvestor@seer.bio
Air Transat to suspend all flights from Toronto, some Montreal routes until April 30 – The Globe and Mail
In a move it blames on tighter restrictions imposed by Ottawa, Transat AT Inc. is halting all flights out of Toronto and some from Montreal for the remainder of the winter travel season.
The route cuts will begin Thursday and last until April 30, Transat spokeswoman Debbie Cabana said.
“Continued travel restrictions and the numerous measures imposed by the federal government, including the requirement to present a negative COVID-19 test and to quarantine upon return to Canada, have had a significant impact on our bookings,” she said.
The cancelled routes in Toronto include flights to Cancun, Mexico; Holguin, Cuba; Punta Cana, Dominican Republic; Varadero, Cuba; Porto, Portugal; and Lisbon, Portugal, Cabana said.
In addition to those flights, Cabana added that Transat is cancelling its flights from Montreal to Puerto Vallarta, Mexico, and Varadero.
The airline notified travel agents of the cancellations in a memo Wednesday, which was obtained by The Canadian Press.
Passengers who paid for their flight or vacation package with cash or credit card will receive a full refund. Passengers currently at their destinations will be rebooked on flights returning to Canada, the memo says.
Transat’s cancellations come just two weeks after Air Canada announced it would lay off 1,700 workers and cut more routes amid a challenging business environment for the aviation industry.
The federal government has cracked down on international travel in recent weeks, implementing a new requirement in January that all travellers seeking to enter Canada provide proof of a negative COVID-19 test taken within 72 hours of departure.
Prime Minister Justin Trudeau has said the federal government is contemplating further restrictions, prompted by the arrival of more contagious strains of COVID-19 in Canada from abroad.
Mr. Trudeau this past weekend reiterated his call for Canadians to cancel any vacations they may have booked, warning that people who travel abroad could face difficulties returning home.
Quebec Premier François Legault has called on Ottawa to go further by banning non-essential travel completely or requiring that new entrants to Canada quarantine in a hotel at their own expense. Similarly, Ontario Premier Doug Ford has called for a temporary ban on flights to Canada from destinations where new variants of COVID-19 have been discovered.
Canada’s airlines have criticized the government’s travel restrictions since the start of the pandemic, arguing that the mandatory 14-day quarantine is overly strict and should be replaced with a testing program at airports.
The airlines have also said the restrictions were rolled out without co-ordination with the industry, leading to confusion and difficulties for passengers. Since the COVID-19 testing mandate went into effect on Jan. 7, airlines have prevented hundreds of Canadians from boarding flights abroad because they did not produce an acceptable test result.
Allison St-Jean, a spokeswoman for Transport Canada, reiterated that Ottawa is committed to assisting airlines and noted that the government is still in negotiations with airlines to develop a financial aid package.
“We are closely following the difficult and unprecedented situation that has unfolded from the heath crisis we are all living through, and that is having a particular impact on this critical sector of the Canadian economy,” Ms. St-Jean said.
Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines. Sign up today.
Real estate expert guest speaker for Ladies Who Lead – Brantford Expositor
Reddit community WallStreetBets squeezes short sellers – ABC News
Cyberpunk 2077 bans unauthorized Keanu Reeves sex – The Verge
Silver investment demand jumped 12% in 2019
Iran anticipates renewed protests amid social media shutdown
Galaxy M31 July 2020 security update brings Glance, a content-driven lockscreen wallpaper service
Tech12 hours ago
PS5 restock at Sony Direct: More consoles expected this week – Tom's Guide
Tech21 hours ago
The 2022 M5 CS Sedan is BMW’s quickest production car ever – Driving
Sports21 hours ago
Schilling requests to be removed from HOF ballot going forward
News21 hours ago
Cheap Auto Insurance in Canada
Health22 hours ago
How other provinces are rolling out the COVID-19 vaccine – CTV News Winnipeg
Tech22 hours ago
The 2022 M5 CS Sedan is BMW’s quickest production car ever
News21 hours ago
Canada seeking exemptions from Biden’s ‘Buy American’ provisions
Health21 hours ago
Central Island continues dominating COVID-19 case counts, active cases dip across B.C.